The 15 references in paper N. Porakhonko A., I. Lapteva M., Н. Порахонько А., И. Лаптева М. (2014) “Влияние легочной гипертензии на толерантность к физической нагрузке при выраженной хронической обструктивной болезни легких // Impact of pulmonary hypertension on exercise tolerance in patients with severe chronic obstructive pulmonary disease” / spz:neicon:pulmonology:y:2012:i:2:p:56-59

1
Chaouat A., Naeije R., Weitzenblum E.Pulmonary hypertension in COPD. Eur Respir. J. 2008; 32: 1371–1385.
(check this in PDF content)
2
Chaouat A., Bugnet A.S., Kadaoui N. et al.Severe pulmonary hypertension and chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2005; 172: 189–194.
(check this in PDF content)
3
Wagner P.D. The real cause of exercise limitation in COPD. J. Appl. Physiol. 2008; 105: 75–78.
(check this in PDF content)
4
Pinto*Plata V.M., Celli*Cruz R.A., Vassaux C. et al. Differences in cardiopulmonary exercise tests results by American Thoracic Society / European Respiratory Societyglobal initiative for chronic obstructive pulmonary disease stage categories and gender. Chest 2007; 132: 1204–1211.
(check this in PDF content)
5
Holverda S., Bogaard H.J., Groepenhoff H. et al. Cardiopulmonary exercise tests characteristics in patients with chronic obstructive pulmonary disease and associated pulmonary hypertension. Respiration 2008; 76: 160–167.
(check this in PDF content)
6
Kitabatake A., Inoue M., Asao M. et al. Noninvasive evaluation of pulmonary hypertension by a pulsed Doppler technique. Circulation 1983; 68: 302–309.
(check this in PDF content)
7
Arcasoy S.M., Christie J.D., Ferrari V.A. et al. Echocardiographic assessment of pulmonary hypertension in patients with advanced lung disease. Am. J. Respir. Crit. Care Med. 2003; 167: 735–740.
(check this in PDF content)
8
O'Donnell D., Webb K.Point-counterpoint: the major limitation to exercise performance in COPD is dynamic hyperinflation. J. Appl. Physiol. 2008; 105: 753–755.
(check this in PDF content)
9
Debigare′R., Maltais F. Point-counterpoint: the major limitation to exercise performance in COPD is lower limb muscle dysfunction. J. Appl. Physiol. 2008; 105: 751–753.
(check this in PDF content)
10
Sun X.G., Hansen E.J., Oudiz R. et al.Exercise pathophysiology inpatients with primary pulmonary hypertension. Circulation 2001; 104: 429–435.
(check this in PDF content)
11
Holverda S., Rietema H., Westerhof N. et al. Stroke volume increases to exercise in COPD is limited by increased pulmonary artery pressure. Heart 2008; 95: 137–141.
(check this in PDF content)
12
Rietema H., Holverda S., Bogaard H.J. et al. Sildenafil treatment in COPD does not affect stroke volume or exercise capacity. Eur. Respir. J. 2008; 31: 759–764.
(check this in PDF content)
13
Vassaux C., Torre*Bouscoulet L., Zeineldine S. et al. Effect of hyperinflation on the oxygen pulse as a marker of cardiac performance in COPD. Eur. Respir. J. 2008; 32: 1275–1282.
(check this in PDF content)
14
Scharf S.M., Iqbal M., Keller C. et al.Hemodynamic characterization of patients with severe emphysema. Am. J. Respir. Crit. Care Med. 2002; 166: 314–322.
(check this in PDF content)
15
Doi M., Nakano K., Hiramoto T., Kohno N.Significance of pulmonary artery pressure in emphysema patients with mild to moderate hypoxemia. Respir. Med. 2003; 97 (8): 915–920. Информация об авторах
(check this in PDF content)